kras mutation and glutathion

kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex KRAS G12D: The Next Frontier

Name: kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex KRAS G12D: The Next Frontier
Brand: crisbcreativa.com
SKU: 44716608469
Price: 21.88 USD
Availability: InStock
Rating: 4.5202 (7 reviews)

KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma

SKU: 44716608469 · From crisbcreativa.com

4.5

USD21.88 USD41.88

Pay in 4 interest-free payments of $5.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Zileuton is a selective inhibitor of 5-lipoxygenase (LOX), an early step in the synthesis of leukotrienes

Transcriptome profiling of sulfur-responsive genes in Arabidopsis reveals global effects of sulfur nutrition on multiple metabolic pathways

Your doctor will recommend only if the benefits outweigh the risks

Emerging studies suggest that individualized dosing strategies and otoprotective agents may reduce the severity of platinum-based drug-induced ototoxicity (Romano et al